New Research Warns Prostate Cancer Overdiagnosis Surges to 58 Percent in Patients Aged 80

Queen Mary University study finds 58% overdiagnosis rate for 80-year-olds. Discover why experts suggest PSA testing is better suited for men in their 50s.

By: AXL Media

Published: Apr 22, 2026, 4:55 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Age Factor in Prostate Screening Efficacy

Recent findings from Queen Mary University of London indicate a profound correlation between a patient's age and the likelihood of receiving a prostate cancer diagnosis that would otherwise never have caused harm. The study, published in the International Journal of Cancer, suggests that while overdiagnosis remains relatively low for younger demographics, it becomes a dominant factor as men age. By examining data from the massive CAP trial involving over 400,000 participants, researchers determined that the clinical value of one-off prostate-specific antigen (PSA) testing varies dramatically depending on the timing of the screen.

Quantifying the Risk of Unnecessary Diagnosis

The statistical analysis shows that for a man diagnosed at age 50, there is only a 16 percent chance that the cancer would have remained undetected within 15 years. However, this figure doubles to 32 percent for those diagnosed at 70, and reaches a staggering 58 percent for patients diagnosed at 80. These figures account for competing mortality, which measures the probability of a patient dying from other causes before the slow-growing prostate cancer could ever manifest as a clinical threat. This data challenges the utility of broad screening programs for the elderly population.

The Clinical Burden of Opportunistic Testing

Current healthcare policies, particularly in regions like the UK, often allow for opportunistic PSA testing on demand, a practice that lead author Dr. Adam Brentnall suggests should be reexamined. According to Dr. Brentnall, older men are at a significantly higher risk of experiencing the harms associated with overdiagnosis, which often leads to unnecessary surgeries and radiotherapy. These interventions carry substantial side effects that can diminish a patient's quality of life, targeting tumors that would have stayed dormant or asymptomatic throughout the remainder of the man's natural lifespan.